Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Vermont

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Vermont, including asynchronous care. What Vermont requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Vermont at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Vermont

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Vermont (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Vermont

18 V.S.A. section 9361 lets a Vermont-licensed health care provider prescribe, dispense, or administer drugs after an appropriate examination performed in person, through telemedicine (defined in 8 V.S.A. section 4098a as live interactive audio and video), or by instrumentation and diagnostic equipment that transmits images and medical records electronically, and it holds electronic prescribing to the same standards as a traditional setting. The section also governs services delivered by store-and-forward means: the patient must be told of the right to refuse that format and ask for a real-time or in-person visit, and originating site providers must obtain informed consent. The Board of Medical Practice telemedicine policy (March 2023), which covers physicians and the other professionals the Board licenses, states that a physician-patient relationship may be established by synchronous or asynchronous telemedicine technologies with no prior in-person meeting, so long as the standard of care is met. Separately, 26 V.S.A. section 1354(a)(33) makes an electronic, online, or telephonic evaluation by questionnaire inadequate for the initial evaluation of a patient, with a narrow exception for an adaptive questionnaire used to prescribe medication to end a pregnancy, and the Board policy says evaluation solely by online questionnaire does not meet the standard of care. The prescriber must be licensed in Vermont or hold a Vermont telehealth license or telehealth registration under 26 V.S.A. chapter 56, issued by the Board of Medical Practice for physicians and by the Office of Professional Regulation for the professions it regulates. GLP-1 medicines and the peptides in this database are not controlled substances. This record classifies asynchronous prescribing as allowed because the statute permits examination through transmitted images and records and the Board policy expressly allows asynchronous establishment of the relationship, but a questionnaire alone is not enough. [4] [5] [6] [7] [8]

Compounded GLP-1 access in Vermont

A pharmacy compounding a GLP-1 for a Vermont patient must hold the appropriate Vermont drug outlet license, including a nonresident license if it ships from out of state. [1] [10] [12]

Research use only sellers in Vermont

Under 26 V.S.A. chapter 36, drugs may be dispensed to Vermont patients only by licensed pharmacists working in licensed drug outlets, so a seller shipping "research use only" injectable peptides to Vermont consumers is not a licensed outlet. [9] [13]

How to check a telehealth provider in Vermont

  1. Confirm the prescriber is licensed or registered to treat patients located in Vermont; the telehealth rules above explain what Vermont requires. [4] [5] [6] [7] [8]
  2. Ask which pharmacy will fill the prescription and check it in the Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) license lookup. [1] [2] [3] [9] [10] [11]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Vermont. [9] [13]

Common questions in Vermont

Does Vermont allow store-and-forward telehealth?

Yes. 18 V.S.A. section 9361 covers services delivered by store-and-forward means. The patient must be told of the right to refuse that format and ask for a real-time or in-person visit instead. The Board of Medical Practice telemedicine policy says a physician-patient relationship may be established by asynchronous technology so long as the standard of care is met. A questionnaire alone is not enough: 26 V.S.A. section 1354(a)(33) treats evaluation by questionnaire as inadequate for the initial evaluation of a patient. Definitions come from 8 V.S.A. section 4098a. [5] [6] [7] [8]

All peptide legal questions for Vermont

Sources

  1. [1]Vermont Board of Pharmacy (Office of Professional Regulation)
  2. [2]Vermont Board of Pharmacy: statutes, rules, and resources
  3. [3]Administrative Rules for the Vermont Board of Pharmacy, effective February 1, 2026 (rules 6-2, 7-4, 10-4, 10-9)
  4. [4]Vermont Office of Professional Regulation
  5. [5]18 V.S.A. section 9361, Health care providers delivering health care services through telemedicine or by store-and-forward means
  6. [6]8 V.S.A. section 4098a, Coverage of health care services delivered through telemedicine and by store-and-forward means (definitions)
  7. [7]26 V.S.A. section 1354, Unprofessional conduct (subdivision (a)(33), prescribing in response to electronic communication)
  8. [8]Vermont Board of Medical Practice: Policy on the Appropriate Use of Telemedicine Technologies in the Practice of Medicine (March 1, 2023)
  9. [9]26 V.S.A. chapter 36, Pharmacy
  10. [10]26 V.S.A. section 2061, Registration and licensure of drug outlets